Get the Stockscreener App
4.2275
1.93%
0.1075
Cargo Therapeutics Inc stock is traded at $4.2275, with a volume of 157.33K.
It is up +1.93% in the last 24 hours and down -1.18% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
See More
Previous Close:
$4.12
Open:
$4.09
24h Volume:
157.33K
Relative Volume:
0.21
Market Cap:
$211.66M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-1.179
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
+0.47%
1M Performance:
-1.18%
6M Performance:
-70.88%
1Y Performance:
-73.75%
1-Day Range:
$4.09
$4.29
1-Week Range:
$4.0712
$4.311
52-Week Range:
$3.00
$25.45
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
4.23 | 211.66M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.55 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
539.68 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.93 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
551.97 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.50 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-30-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-30-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Jan-30-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-30-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-30-25 | Downgrade | Truist | Buy → Hold |
| Jan-30-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 3,570 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews
Millennium Management LLC Invests $1.39 Million in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
BNP Paribas Financial Markets Has $56,000 Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
ProShare Advisors LLC Makes New $171,000 Investment in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Deutsche Bank AG Increases Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Pluri (NASDAQ:PLUR) vs. CARGO Therapeutics (NASDAQ:CRGX) Head-To-Head Review - Defense World
Northern Trust Corp Increases Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Cargo Therapeutics stock rating cut by Jefferies to Hold - MSN
Top Executive Makes a Bold Move with CARGO Therapeutics Stock Sale! - TipRanks
JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising CNS Uptake at American Society of Gene and Cell Therapy 28th Annual Meeting - BioSpace
CARGO Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CARGO Therapeutics (CRGX) Projected to Post Earnings on Tuesday - Defense World
CARGO Therapeutics, Inc. Being Investigated on Behalf of CARGO Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details. - ACCESS Newswire
CARGO Therapeutics Inc expected to post a loss of 67 cents a shareEarnings Preview - TradingView
Truist cuts Cargo Therapeutics rating, slashes PT to $7 - MSN
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Bought by MetLife Investment Management LLC - Defense World
Ratios in Focus: Analyzing CARGO Therapeutics Inc (CRGX)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Bought by Wells Fargo & Company MN - Defense World
Barclays PLC Raises Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
JPMorgan Chase & Co. Raises Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Prepare Yourself for Liftoff: CARGO Therapeutics Inc (CRGX) - Sete News
CARGO Therapeutics Inc (NASDAQ: CRGX): Can A Stock Be -68.31% Lower Year-To-Date And Still Be A Loser? - Marketing Sentinel
Legal & General Group Plc Trims Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Examining the Potential Price Growth of CARGO Therapeutics Inc (CRGX) - knoxdaily.com
Ratio Analysis: Unpacking CARGO Therapeutics Inc (CRGX)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Recent Insider Activity Could Benefit CARGO Therapeutics Inc (CRGX) - knoxdaily.com
What Has Been Going On With CARGO Therapeutics Inc (NASDAQ: CRGX) - Stocksregister
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Acquired by Geode Capital Management LLC - Defense World
Biopharma restructurings reflect strategy of short-term pain for long-term gains - BioWorld MedTech
CARGO Therapeutics Inc’s (NASDAQ: CRGX) Stock Price Will Be Bearish Or Bullish In 2025 - Stocksregister
CRGX: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
Q1 Biopharma Layoffs Hit California, Massachusetts Hard - BioSpace
Vanguard Group Inc. Purchases 22,286 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
American Century Companies Inc. Invests $474,000 in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Rating of “Reduce” from Analysts - Defense World
Cargo Therapeutics executive Anup Radhakrishnan sells $6,522 in stock By Investing.com - Investing.com South Africa
Trial misses sink cancer stocks in Q1: Mersana, Cargo, Mural fall - BioWorld MedTech
Cargo Therapeutics executive Anup Radhakrishnan sells $6,522 in stock - Investing.com
Tango Therapeutics cuts nearly one-fifth of staff - BioPharma Dive
Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Tang Capital’s Concentra nabs a win, making a deal to buy Allakos - Endpoints News
Swiss National Bank Boosts Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Layoffs erase more than 600 Bay Area tech, biotech, hotel, retail jobs - SiliconValley.com
Brokers Offer Predictions for CRGX FY2025 Earnings - Defense World
Is CARGO Therapeutics (NASDAQ:CRGX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Biotech company based in Peninsula laying off 90% of staff - MSN
Finance Watch: Cargo Restructuring Not The News The IPO Market Needs - insights.citeline.com
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cargo Therapeutics Inc Stock (CRGX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Radhakrishnan Anup | See Remarks |
Apr 03 '25 |
Sale |
4.00 |
1,629 |
6,522 |
77,317 |
| Chapman Gina | President & CEO |
Sep 18 '24 |
Option Exercise |
5.03 |
7,166 |
36,045 |
111,071 |
| Chapman Gina | President & CEO |
Sep 19 '24 |
Option Exercise |
5.03 |
2,975 |
14,964 |
106,880 |
| Chapman Gina | President & CEO |
Sep 18 '24 |
Sale |
25.09 |
7,166 |
179,775 |
103,905 |
| Chapman Gina | President & CEO |
Sep 19 '24 |
Sale |
25.03 |
2,975 |
74,457 |
103,905 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Option Exercise |
5.03 |
1,600 |
8,048 |
8,046 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Sale |
25.28 |
1,600 |
40,452 |
6,446 |
0.75%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):